Manulife (Manufacturers Life Insurance)’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-72,155
| Closed | -$441K | – | 2942 |
|
|
2024
Q4 | $441K | Sell |
72,155
-2,457
| -3% | -$15K | ﹤0.01% | 2297 |
|
|
2024
Q3 | $1.23M | Buy |
74,612
+5,683
| +8% | +$94K | ﹤0.01% | 1815 |
|
|
2024
Q2 | $474K | Sell |
68,929
-1,572
| -2% | -$10.8K | ﹤0.01% | 2241 |
|
|
2024
Q1 | $680K | Buy |
70,501
+21,559
| +44% | +$208K | ﹤0.01% | 2059 |
|
|
2023
Q4 | $407K | Hold |
48,942
| – | – | ﹤0.01% | 2264 |
|
|
2023
Q3 | $409K | Hold |
48,942
| – | – | ﹤0.01% | 2231 |
|
|
2023
Q2 | $452K | Buy |
48,942
+11,286
| +30% | +$104K | ﹤0.01% | 2107 |
|
|
2023
Q1 | $517K | Hold |
37,656
| – | – | ﹤0.01% | 1988 |
|
|
2022
Q4 | $614K | Buy |
37,656
+35
| +0.1% | +$571 | ﹤0.01% | 1852 |
|
|
2022
Q3 | $746K | Sell |
37,621
-161
| -0.4% | -$3.19K | ﹤0.01% | 1740 |
|
|
2022
Q2 | $695K | Buy |
37,782
+6,364
| +20% | +$117K | ﹤0.01% | 1825 |
|
|
2022
Q1 | $814K | Buy |
+31,418
| New | +$814K | ﹤0.01% | 1876 |
|
|
2021
Q4 | – | Sell |
-4,749
| Closed | -$312K | – | 3145 |
|
|
2021
Q3 | $312K | Sell |
4,749
-448
| -9% | -$29.4K | ﹤0.01% | 2640 |
|
|
2021
Q2 | $432K | Buy |
5,197
+499
| +11% | +$41.5K | ﹤0.01% | 2543 |
|
|
2021
Q1 | $360K | Sell |
4,698
-32
| -0.7% | -$2.45K | ﹤0.01% | 2494 |
|
|
2020
Q4 | $418K | Buy |
4,730
+4
| +0.1% | +$353 | ﹤0.01% | 2311 |
|
|
2020
Q3 | $349K | Hold |
4,726
| – | – | ﹤0.01% | 2189 |
|
|
2020
Q2 | $321K | Buy |
4,726
+952
| +25% | +$64.7K | ﹤0.01% | 2203 |
|
|
2020
Q1 | $212K | Buy |
+3,774
| New | +$212K | ﹤0.01% | 2292 |
|